Experimental group:Quercetin

2 trials

Sponsors

Second Affiliated Hospital of Army Medical University, PLA

Conditions

nonalcoholic fatty liver disease (NAFLD)

Early Phase 1

Effects of quercetin supplement on liver fatty deposition in patients with NAFLD: a randomized, double-blind, placebo-controlled, cross-over trial

Active, not recruitingChiCTR2100047904

Second Affiliated Hospital of Army Medical University, PLAnonalcoholic fatty liver disease (NAFLD)

Start: 2021-07-01Updated: 2022-03-07

Effects of quercetin supplement on liver fatty deposition in patients with NAFLD: a randomized, double-blind, placebo-controlled, cross-over trial

Active, not recruitingITMCTR2100004988

Second Affiliated Hospital of Army Medical University, PLAnonalcoholic fatty liver disease (NAFLD)

Start: 2021-07-01Updated: 2023-02-20

Related Papers

Quercetin intervention reduced hepatic fat deposition in patients with nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled crossover clinical trial.

2024-07-1925 citations